HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

153 Samarium-EDTMP in myeloablative dosage followed by a second autotransplantation in patients with relapsed multiple myeloma.

AuthorsStefan Knop, Bernhard M Dohmen, Lothar Kanz, Roland Bares, Hermann Einsele
JournalHaematologica (Haematologica) Vol. 89 Issue 9 Pg. ECR36 (Sep 2004) ISSN: 1592-8721 [Electronic] Italy
PMID15377488 (Publication Type: Case Reports, Evaluation Study, Journal Article)
Chemical References
  • Organometallic Compounds
  • Organophosphorus Compounds
  • Radioisotopes
  • Radiopharmaceuticals
  • (ethylenedinitrilo)-tetramethylenephosphonic acid
  • Samarium
  • samarium Sm-153 lexidronam
  • Melphalan
Topics
  • Fatal Outcome
  • Graft Survival
  • Humans
  • Male
  • Melphalan (therapeutic use)
  • Multiple Myeloma (complications, radiotherapy, surgery)
  • Organometallic Compounds (pharmacokinetics, therapeutic use)
  • Organophosphorus Compounds (pharmacokinetics, therapeutic use)
  • Osteolysis (etiology, radiotherapy)
  • Peripheral Blood Stem Cell Transplantation
  • Radioisotopes (pharmacokinetics, therapeutic use)
  • Radiopharmaceuticals (pharmacokinetics, therapeutic use)
  • Salvage Therapy
  • Samarium (pharmacokinetics, therapeutic use)
  • Transplantation Conditioning
  • Transplantation, Autologous
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: